Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer
about
Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
Sorafenib in Treating Patients ...... urgery to Remove Kidney Cancer
@en
type
label
Sorafenib in Treating Patients ...... urgery to Remove Kidney Cancer
@en
prefLabel
Sorafenib in Treating Patients ...... urgery to Remove Kidney Cancer
@en
P6153
P1132
P1476
SORCE: A Phase III Randomised ...... r Intermediate Risk of Relapse
@en
P3098
NCT00492258
P4844
P580
2007-06-01T00:00:00Z
P582
2012-08-01T00:00:00Z